Sign in with Google. Opens in new tab

Henlius (2696 HK): Test of Nerves Awaiting LVC’s Next Move

681 Views13 Jan 2025 07:58
There are valid arguments for LVC to block the vote and support the offer. LVC’s trading behaviour over the coming days will point to its voting intentions.
What is covered in the Full Insight:
  • Introduction to the Fosun Pharma Offer
  • Gross Spread Dynamics
  • LVC's Shareholding and Vote Considerations
  • Rationale for Supporting the Offer
  • Potential Reasons for Blocking the Offer
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Arun George
IPOs and Catalysts/Events
Global Equity Research Ltd
Information TechnologyEquitiesEquity Capital MarketsEvent-Driven
Price Chart(Sign Up to Access)
analytics-chart
x